AwardedPRTGoodsFramework agreement€470,250
IMUNOMODULADORES - PEMBROLIZUMAB - 2 MESES
- Published
- Published 29 June 2026
Overview
Serviços de Saúde da Região Autónoma da Madeira procured immunomodulatory medication (Pembrolizumab) for a two-month supply period. The contract was awarded to Merck Sharp & Dohme, LDA on 25 June 2026 for a value of EUR 470,250.
Key details
- Country
- PRT
- Status
- Awarded
- Category
- Goods
- Estimated value
- €470,250
- Procedure
- Selective
- Contract type
- Framework agreement
- Published
- 29 June 2026
Pharmaceutical productsVarious medicinal products
Award outcome
- Awarded value
- €470,250
- Award date
- 25 June 2026
- Contract period
- — → 24 August 2026
- MERCK SHARP & DOHME,LDA -MSD
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
29 June 2026
Contracting authority
Serviços de Saúde da Região Autónoma da Madeira, EPERAM (SESARAM; EPERAM)
Procuring entityFunchal, PRT
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.